Iteos Therapeutics SA, a privately-held biotechnology company developing novel cancer immunotherapies, last week announced the appointment of Matthew Call as its Chief Operating Officer. Matthew will also be responsible for business development.
Although it has only been shown to provide partial protection, the first-ever malaria vaccine is in testing in Africa – and there are many more hopefuls in the pipeline. Will we soon eradicate one of the most deadly pathogens in human history?
https://european-biotechnology.com/wp-content/uploads/2024/04/ebcom_2019_malariasdoom.png5631000Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2019-08-19 15:13:052024-04-02 16:20:41The Dawn of Malaria’s Doom
The FDA has given the go-ahead to PharmaMar’s proposal to file for accelerated approval its New Drug Application (NDA) for lurbinectedin monotherapy for the treatment of second-line small-cell lung cancer.
Researchers at Karolinska Institutet have discovered a new sensory receptor organ that is able to detect painful mechanical damage, such as pricks and impacts.
https://european-biotechnology.com/wp-content/uploads/2024/04/Karolinska.jpg10001500Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2019-08-16 09:35:422019-08-16 09:35:42Swedish researchers find new pain organ
https://european-biotechnology.com/wp-content/uploads/2024/04/Pharming-headquarters.jpg8531280Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2019-08-13 09:56:012019-08-13 09:56:01Pharming licenses orphan drug from Novartis
https://european-biotechnology.com/wp-content/uploads/2024/04/Zahnstammzellen.jpg10001161Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2019-08-12 07:42:462019-08-12 07:42:46New stem cell population may help repair teeth
Using a platform tailored to patients’ specific cancer mutations, British and US researchers for the first time detected residual disease in breast cancer patients.
https://european-biotechnology.com/wp-content/uploads/2024/04/CtDNA_in_circulation.png520726Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2019-08-08 06:15:422019-08-08 06:15:42Liquid biopsy identifies residual breast cancer
Matthew Call joins Iteos as COO
AppointmentsIteos Therapeutics SA, a privately-held biotechnology company developing novel cancer immunotherapies, last week announced the appointment of Matthew Call as its Chief Operating Officer. Matthew will also be responsible for business development.
The Dawn of Malaria’s Doom
BackgroundAlthough it has only been shown to provide partial protection, the first-ever malaria vaccine is in testing in Africa – and there are many more hopefuls in the pipeline. Will we soon eradicate one of the most deadly pathogens in human history?
PharmaMar moves ahead with NDA for Zepsyre
Latest NewsThe FDA has given the go-ahead to PharmaMar’s proposal to file for accelerated approval its New Drug Application (NDA) for lurbinectedin monotherapy for the treatment of second-line small-cell lung cancer.
Innovative analytical methods for particulate characterization
Sponsored PublicationsManufacturers respond to stricter regulations with novel approaches.
Swedish researchers find new pain organ
Latest NewsResearchers at Karolinska Institutet have discovered a new sensory receptor organ that is able to detect painful mechanical damage, such as pricks and impacts.
Researchers unravel potential cancer target
Latest NewsBritish researchers have found out what’s going wrong with chromosome segregation in some cancers.
Pharming licenses orphan drug from Novartis
Latest NewsNew stem cell population may help repair teeth
Latest NewsResearchers have discovered that crosstalk of a newly discovered stem cell population with quiescent stem cells may help repair teeth in the future.
Bayer bags iPSC specialist BlueRock Therapeutics
Latest NewsBayer has widened its pipeline in neurology, cardiology, and immunology by acquiring induced pluripotent stem cell specialist BlueRock Therapeutics.
Liquid biopsy identifies residual breast cancer
Latest NewsUsing a platform tailored to patients’ specific cancer mutations, British and US researchers for the first time detected residual disease in breast cancer patients.